Roche Rebounds, Lilly Lifts, Sanofi Rolls On: Big Pharma China Roundup
This article was originally published in PharmAsia News
2015 ended with a corporate report card that delighted some but disappointed others, with sales performances veering wildly between growth of more than 20% to declines of about the same. PharmAsia News has combed through multinationals’ earnings reports to bring you the winners, laggards and most successful strategies.
Register for our free email digests: